Literature DB >> 6424137

Lipoxygenase activity of intact human platelets.

M Lagarde, M Croset, D Boukhchache, A Greffe, M Dechavanne, S Renaud.   

Abstract

The oxygenation by lipoxygenase of different icosaenoic and docosaenoic acids by intact human platelets was studied. The HPLC analysis of the hydroxy compound (s) derived from icosaenoic acids showed that the 12-derivatives predominate. The increase of the fatty acid concentration markedly enhanced their oxygenation except for icosapentaenoic acid. The conversion of this acid into its hydroxy derivative rose in the presence of arachidonic acid, probably through both its cyclo-oxygenase and lipoxygenase product formation. Since 12-hydroxy-icosaenoic acids are modulators of PGH2-induced platelet aggregation, we conclude that the interactions between polyunsaturated fatty acids during their oxygenation by platelet lipoxygenase could be relevant to the regulating activity of dietary fatty acids.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424137     DOI: 10.1016/0262-1746(84)90103-3

Source DB:  PubMed          Journal:  Prostaglandins Leukot Med        ISSN: 0262-1746


  4 in total

1.  Activation of the human neutrophil 5-lipoxygenase by exogenous arachidonic acid: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins.

Authors:  S R McColl; E Krump; P H Naccache; A C Caon; P Borgeat
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

2.  Subcellular localization and some properties of lipoxygenase activity in human blood platelets.

Authors:  M Lagarde; M Croset; K S Authi; N Crawford
Journal:  Biochem J       Date:  1984-09-01       Impact factor: 3.857

3.  Thrombocytopenia induced by erucic acid therapy in patients with X-linked adrenoleukodystrophy.

Authors:  S Zierz; R Schröder; C J Unkrig
Journal:  Clin Investig       Date:  1993-10

4.  Pasteurella haemolytica leukotoxin enhances production of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by bovine polymorphonuclear leukocytes.

Authors:  P A Henricks; G J Binkhorst; A A Drijver; F P Nijkamp
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.